Opus Genetics, Inc.
IRD
$0.8905
$0.02552.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -57.53M | -27.19M | -14.11M | -11.30M | -9.99M |
| Total Depreciation and Amortization | 10.00K | 3.00K | 4.00K | 5.00K | 6.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.86M | 3.27M | 4.34M | 4.96M | 4.79M |
| Change in Net Operating Assets | 3.09M | 10.33M | -1.70M | 3.16M | 4.08M |
| Cash from Operations | -25.58M | -13.59M | -11.46M | -3.18M | -1.11M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.21M | -- | -- | -- | -- |
| Cash from Investing | 1.21M | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.50M | 8.27M | 13.30M | 11.74M | 9.26M |
| Repurchase of Common Stock | -79.00K | -42.00K | -42.00K | -42.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -232.00K | -358.00K | -361.00K | -339.00K | -278.00K |
| Cash from Financing | 4.19M | 7.87M | 12.90M | 11.36M | 8.98M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.18M | -5.72M | 1.43M | 8.17M | 7.87M |